Onconic Therapeutics Calls Extraordinary Shareholder Meeting

Onconic Therapeutics will hold an extraordinary shareholders meeting on Nov. 26, 2026, at 9 a.m. in Seoul. Shareholders will vote on expanding the board and appointing independent directors and audit committee members for three-year terms. Lee Kyung-min’s appointments require Public Service Ethics Committee employment approval on Nov. 20, 2026; otherwise, the votes will not proceed. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Onconic Therapeutics Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261016900750), on October 16, 2026, and is solely responsible for the information contained therein. (C)